Efficacy of snap-needle patch therapy in pediatric epilepsy: a case study

After a systematic literature search, this study represents the first case report of BECTS treated with snap-needle therapy (needle size: 0.220 mm × 1.5 mm). In this case, the child's GTCSs resolved following the addition of snap-needle therapy, and oral antiepileptic medication was gradually reduced to complete discontinuation; no seizure recurrence was observed within 1 year of follow-up. It is important to acknowledge that the contributions of medication adjustments and the self-limiting nature of BECTS cannot be ruled out in this case. However, based on the observations here, we propose the hypothesis that snap-needle intervention is likely associated with seizure remission. Although the mechanism underlying snap-needle therapy for BECTS remains unclear, the child achieved a QOLCE-16-C score of 98.4 at the end of treatment; during the 1-year follow-up, the number of nighttime sleep disruptions also decreased from 2 to 5 episodes per year to 0. These outcomes surpass those typically achievable through pharmacological intervention alone.